Charles Schwab Investment Management Inc Optimize Rx Corp Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Optimize Rx Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 41,552 shares of OPRX stock, worth $235,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,552

Previous 48,437 14.21%

Holding current value

$235,184

Previous $373,000 46.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$3.83 - $7.83 $26,369 - $53,909	-6,885 Reduced 14.21%	41,552 $201,000
Q2 2024 Aug 12, 2024	BUY	$8.8 - $13.17 $47,572 - $71,197	5,406 Added 12.56%	48,437 $484,000
Q1 2024 May 08, 2024	SELL	$11.47 - $16.17 $21,471 - $30,270	-1,872 Reduced 4.17%	43,031 $522,000
Q2 2023 Aug 09, 2023	SELL	$11.63 - $15.63 $69 - $93	-6 Reduced 0.01%	44,903 $641,000
Q1 2023 May 11, 2023	SELL	$12.54 - $19.38 $26,923 - $41,608	-2,147 Reduced 4.56%	44,909 $657,000
Q4 2022 Feb 13, 2023	SELL	$13.77 - $22.04 $12,365 - $19,791	-898 Reduced 1.87%	47,056 $790,000
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $22,066 - $48,388	1,606 Added 3.47%	47,954 $712,000
Q2 2022 Aug 15, 2022	BUY	$21.94 - $40.49 $27,315 - $50,410	1,245 Added 2.76%	46,348 $1.27 Million
Q1 2022 May 13, 2022	BUY	$35.27 - $62.91 $36,433 - $64,986	1,033 Added 2.34%	45,103 $1.7 Million
Q4 2021 Feb 11, 2022	BUY	$53.57 - $98.0 $38,195 - $69,874	713 Added 1.64%	44,070 $2.74 Million
Q3 2021 Nov 16, 2021	BUY	$50.93 - $85.55 $153,299 - $257,505	3,010 Added 7.46%	43,357 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$42.76 - $63.33 $31,214 - $46,230	730 Added 1.84%	40,347 $2.5 Million
Q1 2021 May 17, 2021	BUY	$33.36 - $62.2 $129,003 - $240,527	3,867 Added 10.82%	39,617 $1.93 Million
Q4 2020 Feb 16, 2021	BUY	$19.04 - $33.1 $52,645 - $91,521	2,765 Added 8.38%	35,750 $1.11 Million
Q3 2020 Nov 13, 2020	SELL	$12.99 - $21.78 $13,964 - $23,413	-1,075 Reduced 3.16%	32,985 $688,000
Q2 2020 Aug 14, 2020	BUY	$8.34 - $13.69 $17,180 - $28,201	2,060 Added 6.44%	34,060 $444,000
Q3 2019 Nov 08, 2019	BUY	$13.6 - $16.96 $54,699 - $68,213	4,022 Added 14.38%	32,000 $464,000
Q2 2019 Aug 09, 2019	BUY	$10.43 - $16.62 $291,810 - $464,994	27,978 New	27,978 $454,000

Others Institutions Holding OPRX

# of Institutions

Shares Held

13M

Call Options Held

800

Put Options Held

18.1K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $102M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Optimize Rx Corp Transaction History